About the LN-IHC Tool

Overview:

The InterLymph Consortium, or formally the International Consortium of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies, is an open scientific forum for epidemiologic research in non-Hodgkin's lymphoma. Formed in 2001, the Consortium is a group of international investigators who have completed or have ongoing case-control studies and who discuss and undertake research projects that pool data across studies or otherwise undertake collaborative research.

To visit the InterLymph web page and learn more, please visit the InterLymph website.

Pathology Working Group:

The Pathology Working Group within InterLymph is composed of expert hematopathologists, epidemiologists, and other investigators with an interest in disease classification.

Citation:

  1. Turner, J. J., et al. (2010). InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood, The Journal of the American Society of Hematology, 116(20), e90-e98.
  2. Morton, L. M., et al. (2007). Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood, The Journal of the American Society of Hematology, 110(2), 695-708.
  3. Pathology Working Group (2024). InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2022): update and future directions. LN Journal, The Journal of the LNs.

Data Sources:

Updates: